Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate GOP Import Bill Would Establish Internet Pharmacy Licensing Procedure

This article was originally published in The Pink Sheet Daily

Executive Summary

Legislation sponsored by Sen. Gregg would prohibit Web service providers from accepting advertisements for unlicensed Internet pharmacies. Credit card companies would also be barred from enabling financial transactions with unlicensed pharmacies.

You may also be interested in...



"Canadian Generics" Website Products Differ In Potency From U.S. Versions, FDA Finds

FDA tests show a "generic" version of Ambien purchased through a website advertising "Canadian Generics" was more potent than the U.S. version. The "generic" Lipitor and Viagra were both subpotent.

"Canadian Generics" Website Products Differ In Potency From U.S. Versions, FDA Finds

FDA tests show a "generic" version of Ambien purchased through a website advertising "Canadian Generics" was more potent than the U.S. version. The "generic" Lipitor and Viagra were both subpotent.

Senate Expected To Block Rx Import Amendments To Pending Bills

Senate Republicans will only “entertain relevant amendments” to a class action reform bill being debated on the floor, a staffer says, pushing consideration of drug import legislation until the fall following committee debate.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059850

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel